Poseidon
General Information
Overview
Management of patients with an impaired ovarian reserve or poor ovarian response (POR) to exogenous gonadotropin stimulation has challenged reproductive specialists for years. Apart from the limited understanding of its pathophysiology, there is wide heterogeneity in defining POR and overall disappointing outcomes in assisted reproductive technology (ART) cycles.
The First POSEIDON’s World Conference will dissect the new POSEIDON criteria as a means to improve the management of patients exposed to assisted reproductive technology. The new criteria enable discussion of novel approaches catered specifically to patients with low prognosis during IVF, thereby offering better tools to optimise IVF success rates.
The programme will engage renowned international experts with vast clinical experience in constantly evolving subjects. The programme aims to impart specific knowledge with focus on changing concepts or practices.
Learning Objectives
With this conference, the participants will get acquainted with the state-of-the-art definition of impaired response to ovarian stimulation, comprehend the new low prognosis concept and its application in clinical practice, and individualise and manage women with expected or unexpected prognosis to ART as per the POSEIDON classification.
Target Audience
The program is intended for clinicians, embryologists, andrologists, scientists, and managers working in ART who wish to update their knowledge of advanced techniques and scientific innovations and understand best practices using evidence-based models of care.
Accreditation
This programme will be submitted for CME accreditation to EACCME® (European Accreditation Council for Continuing for Medical Education).
Through an agreement between the European Union of Medical Specialists (UEMS) and the American Medical Association (AMA), physicians may convert EACCME credits to an equivalentnumber of AMA PRA Category 1 Credits TM . Information on the process to convert EACCME credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications.
Partnership
This program is designed in partnership with:
- Italian Society of Fertility and Sterility www.sifes.it
- POSEIDON Patient Oriented Strategies Encompassing IndividualizeD Oocyte Number www.groupposeidon.com
- The Portuguese Society of Reproductive Medicine www.spmr.pt
- TSRM, the Turkish Reproductive Health Association www.tsrm.org.tr/pro/en/
- University of Naples Federico II – Naples, Italy www.unina.it
Chairs
Faculty
Carlo Alviggi
Federico II University
Naples, Italy
Klaus Bühler
Centre for Reproductive Medicine & Gynaecological Endocrinology
Stuttgart, Germany
Alessandro Conforti
Federico II University
Naples, Italy
Sandro C. Esteves
Androfert – Andrology and Human Reproduction Clinic
Campinas, Brazil
Robert Fischer
Fertility Centre Hamburg
Hamburg, Germany
Peter Humaidan
Skive Regional Hospital and Faculty of Health
Aarhus University
Fertility Clinic
Skive, Denmark
Antonio La Marca
University of Modena and Reggio Emilia
Clinical Activity of Clinica Eugin Modena
Modena, Italy
Thi Ngoc Lan Vuong
University of Medicine and Pharmacy at Ho Chi Minh City
Ho Chi Minh City, Vietnam
Raoul Orvieto
Tel-Aviv University
Tel-Aviv, Israel
Filippo Maria Ubaldi
G.E.N.E.R.A. Centre for Reproductive Medicine
Rome, Italy
Sesh K. Sunkara
King’s College London
London, UK
Pedro Xavier
Hospital Center São João
Porto, Portugal
Hakan Yarali
Anatolia IVF and Women’s Health Center
Ankara, Turkey
Scientific programme
9 - 10 September 2022
Friday, 9 September 2022
08:00
Registration
09.00
MedEA Welcome
Robert Fischer, Germany
09.10
Local welcome
Pedro Xavier, Portugal
09.20
Introduction and objectives
Sandro Esteves, Brazil
Session I
Chairs: Peter Humaidan, Denmark / Pedro Xavier, Portugal
09.30
L1 Why we need new criteria for the low prognosis patient: a historical overview
Carlo Alviggi, Italy
09.55
L2 The POSEIDON criteria explained
Peter Humaidan, Denmark
10.20
L3 Female age, oocyte competence and beyond: the relevance for the POSEIDON criteria
Filippo Ubaldi, Italy
10.45
Discussion
11.15
Coffee break
Saturday, 10 September 2022
Session II
Chairs: Sandro Esteves, Brazil / Hakan Yarali, Turkey
11.35
L4 Antral follicle count and anti-Mullerian hormone: essential pillars of the POSEIDON criteria
Antonio La Marca, Italy
12.00
L5 The oocyte number and the relationship with low prognosis
Sesh K. Sunkara, UK
12.25
L6 FSH and LH deficiency in MAR treatments: advanced female age, treatment factors and genetics
Pedro Xavier, Portugal
12.50
Discussion
13.20
Lunch
Session III
Chairs: Robert Fischer, Germany / Sesh Sunkara, UK
14.20
L7 Ovarian hypo-response to COS and its proposed metrics: The FORT and the FOI
Alessandro Conforti, Italy
14.45
L8 The ART calculator: a validated tool to predict reproductive success in ART
Sandro Esteves, Brazil
15.10
L9 The POSORT guidelines: improving study design and reporting of clinical trials
Raoul Orvieto, Israel
15.35
Discussion
16.05
End of the first day
Session IV
Chairs: Carlo Alviggi, Italy / Robert Fischer, Germany
10.00
L10 POSEIDON in clinical practice: incidence and characteristics: insights from multinational real-world data
Hakan Yarali, Turkey
10.25
L11 Cumulative Live Birth Rates in POSEIDON patients: real-world evidence
Lan Vuong, Vietnam
10.50
Discussion
Session V
Chairs: Sandro Esteves, Brazil / Pedro Xavier, Portugal
11.30
L12 Management strategies in POSEIDON groups 1 and 2 patients
Klaus Bühler, Germany
11.55
L13 Management strategies in POSEIDON groups 3 and 4 patients
Robert Fischer, Germany
12.20
L14 The POSEIDON group: what did we achieve and what’s next? (Optional)
Carlo Alviggi, Italy
12.45
Discussion
13.10
Concluding remarks
13.20
End of the Conference and Closing Lunch
Download Programme
General Information
Venue
Lisbon, Portugal
Centro de Congressos do Estoril
www.estorilcc.com
Language
The official language of the activity will be English.
CME Provider
Med.E.A – Medical Education Academy
Chloe Xilinas: Programme and Relations Manager in Medical Education
chloe.xilinas@medea.academy
Registration
The First POSEIDON’s World Conference (9-10 September 2022) will be held in partnership with the Portuguese Society of Assisted Reproduction Conference (International Meeting of Reproductive Medicine Societies – 8 September 2022).
Participants will be able to register for both conferences:
- Registration fee to the First POSEIDON’s World Conference (9-10 September 2022)
: 225€*
- Registration fee to the First POSEIDON’s World Conference (9-10 September 2022)
– Only for POSEIDON members www.groupposeidon.com
: 180€*
- Joint registration fee to the First POSEIDON’s World Conference (9-10 September 2022)
& International Meeting of Reproductive Medicine Societies (8 September)
: 275€*
The registration includes:
- Scientific sessions
- Coffee breaks and lunch
- Educational materials
- Certificate of attendance
Conference Dinner on 9 September 2022 is not included
Please send us the request for registration, accommodation and conference dinner (to be held on 9 September 2022) no later than 31 May 2022, after this date, consider registration and accommodation will be on a first-come, first-served basis.
For further logistics enquiries, please contact EVENT PLANET SRL: poseidon@eventplanetgroup.com
Funding
Med.E.A Srl educational programs are organized solely to promote the exchange and dissemination of scientific and medical information. No forms of promotional activities are permitted. There may be presentations discussing investigational uses of various products.
These views are the responsibility of the named speakers and do not represent an endorsement or recommendation on the part of Med.E.A. Srl. Our educational activities are supported by independent grants from the Healthcare business of Merck KGaA, Darmstadt, Germany; FUJIFILM EUROPE GMBH, Fujifilm Italia S.p.A., FUJIFILM France S.A.S.